Mercer Global Advisors Inc Heron Therapeutics, Inc. Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$10.23 - $24.56 $424,248 - $1.02 Million	-41,471 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $37,557 - $57,371	2,156 Added 5.48%	41,471 $975,000
Q3 2019 Nov 12, 2019	BUY	$16.36 - $21.39 $41,930 - $54,822	2,563 Added 6.97%	39,315 $727,000
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $30,474 - $47,196	-1,800 Reduced 4.67%	36,752 $683,000
Q1 2019 Apr 23, 2019	BUY	$23.15 - $28.34 $93,063 - $113,926	4,020 Added 11.64%	38,552 $942,000
Q1 2019 Apr 12, 2019	BUY	$23.15 - $28.34 $799,415 - $978,636	34,532 New	34,532 $896,000

173

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $204M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.